Decline depth
-60.6%
From rolling 252-day high of $13.24, 299d ago.
Past the 40% Red List threshold.
-60.6%
from rolling 252-day high of $13.24 set 2025-07-21 · 299d ago
Current
$5.22
Decline depth
-60.6%
Decline σ
1.0σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
REPL qualifies for the Red List on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
1.0σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (13.86% per day).
The structural read
What price action says about REPL.
REPL qualifies for the Red List on decline depth — down -60.6% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.
Earnings on file: 2026-02-03. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $1.50
31.7% of range
52W high $13.24
Sector context · Healthcare
215 other Healthcare tickers are on Broken Stocks.
106
Red List
57
Amber
52
Watch
-34.1%
Median decline
Worst in sector: OPRX (-76.6%). Least-bad: KYMR (-20.2%). See all Healthcare listings →
Related — same sector
Closest decliners to REPL
Red List
JANX
Janux Therapeutics, Inc.
Red List
SPRY
ARS Pharmaceuticals, Inc.
Red List
SLP
Simulations Plus, Inc.
Red List Recovering
PRCT
PROCEPT BioRobotics Corporation
Red List
SRPT
Sarepta Therapeutics, Inc.
Red List
CLPT
ClearPoint Neuro Inc.
Questions about REPL
What people ask.
Why is REPL on Broken Stocks?
REPL qualifies for the Red List on decline depth. It is down -60.6% from its rolling 252-day high of $13.24, set on 2025-07-21 — 299d ago.
Is REPL a falling knife?
Not by the strict technical definition. REPL is down -60.6% from its 52-week high, but that high was set 299d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. REPL is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is REPL a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is REPL trading inside its 52-week range?
At $5.22, REPL sits 31.7% of the way from its 52-week low ($1.50) to its 52-week high ($13.24). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has REPL been declining?
The current 60.6% decline accrued over 299d, which annualizes to roughly -74.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does REPL compare to its sector?
There are 215 other Healthcare tickers on Broken Stocks: 106 Red, 57 Amber, 52 Watch, with 24 showing recovering structural signals. Median sector decline is -34.1% — REPL's decline is deeper than the sector median.
Does REPL's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-03) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.